Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FX7Q2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,034
Award facts
- Contract value 100% obligated
- $22,034.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of 200-unit vials of Botox, a specialized pharmaceutical product, with a ceiling value of $22,034.40. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025.
DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.
The contract award does not have a set-aside designation, which allows DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides critical pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.
Quick answers
Who was awarded contract SPE2DB25FX7Q2?
SPE2DB25FX7Q2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 31, 2025.
How much is contract SPE2DB25FX7Q2 worth?
The government has obligated $22,034 on SPE2DB25FX7Q2.
Is contract SPE2DB25FX7Q2 an order under another contract?
Yes. SPE2DB25FX7Q2 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7Q2 competed?
The extent of competition for SPE2DB25FX7Q2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award